Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Cell Biotech Co., Ltd. (049960)
Market Open
11 Aug, 05:27
KRX SM
All
(1)
KR
(1)
KRX SM
Primary
₩
16,050.
00
+150
+0.9434%
₩
111.76B
Market Cap
-
P/E Ratio
2,400%
Div Yield
38,954
Volume
-
Eps
₩
15,900
Previous Close
Watching
Watch
Add Transaction
Day Range
15,900
16,640
Year Range
11,350
18,500
Want to track
049960
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Statistics
Historical Data
Cell Biotech Co., Ltd. (049960) Statistics
Valuation metrics
Market Cap
111.76B
Enterprise value
95.05B
Trailing P/E (ttm)
11.04
Forward P/E
-
PEG ratio
0.07
Price/Sales (ttm)
2.1
Price/Book (mrq)
0.84
Enterprise Value/Revenue
1.79
Enterprise Value/EBITDA
6.72
Overview
Shares outstanding
6.84M
Float
-
Shares short
-
% Held by insiders
-
% Held by institutions
-
Average volume (10 days)
29.56K
Average volume (90 days)
31.85K
Price summary
52-Week low
11,350
52-Week high
18,500
Beta
-
50-Day moving average
15,916.8
200-Day moving average
13,773.1
Dividends and splits
Forward annual dividend rate
2,400
Forward annual dividend yield
0.147%
Trailing annual dividend rate
600
Trailing annual dividend yield
0.0367%
5-Year annual dividend yield
-
Payout ratio
-
Dividend Date
5 Jan 2026
Ex-Dividend Date
29 Dec 2025
Last split factor
-
Last split Date
-
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
0.73%
Operating margin
0.21%
Operational effectiveness
Return on assets
0.07%
Return on equity
0.08%
Income Statement
Revenue (ttm)
53.13B
Revenue per share (ttm)
7,760.14
Quarterly revenue growth (yoy)
-0%
Gross profit (ttm)
38.62B
EBITDA
18.65B
Net income to common (ttm)
10.13B
Diluted EPS (ttm)
1,479
Quarterly earnings growth (yoy)
0.3%
Balance Sheet
Total cash (mrq)
26.72B
Total cash per share (mrq)
3,903.75
Total debt (mrq)
293.41M
Total Debt/Equity (mrq)
0
Current ratio (mrq)
10.5%
Book value per share (mrq)
19,438.61
Cash Flow
Cash flow statement
7.27B
Levered free cash flow (LFCF)
10.13B